Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025 (14:03 - 14:22)
Organised by: 
Abstract
Slides
About the speaker
Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)
2 More presentations in this session
Professor L. Badimon (Barcelona, ES)
Access the full session
The Event
ESC Congress 2025
1 September 2025
14:03 CET
